AxioMx seeks Ph.D. research scienist … more

AxioMx sees MS/BS technical associate … more

Headquartered in Branford, AxioMx is applying knowledge gained from the past 15 years of human genome sequencing to produce highly specific recombinant antibodies against the human proteome. The company has developed synthetic recombinant antibody libraries, commonly known as phage display libraries, with greater than ten billion unique clones.